Prior Gemtuzumab Ozogamicin Exposure in Adults with Acute Myeloid Leukemia Does Not Increase Hepatic Veno-Occlusive Disease Risk after Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prior Gemtuzumab Ozogamicin Exposure in Adults with Acute Myeloid Leukemia Does Not Increase Hepatic Veno-Occlusive Disease Risk after Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis

Published:2020-05 Issue:5 Volume:26 Page:884-892
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Ho Vincent T.,Martin Andrew St.,Pérez Waleska S.,Steinert Patricia,Zhang Mei-Jie,Chirnomas Deborah,Hoang Caroline J.,Loberiza Fausto R.,Saber Wael^ORCID

Funder

National Institutes of Health

National Heart, Lung, and Blood Institute

National Cancer Institute

Office of Naval Research

Health Resources and Services Administration

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference34 articles.

1. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: novel insights to pathogenesis, current status of treatment, and future directions;Richardson;Biol Blood Marrow Transplant,2013

2. Venoocclusive disease of the liver following bone marrow transplantation;Jones;Transplantation,1987

3. Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome;Coppell;Biol Blood Marrow Transplant,2010

4. The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade;Carreras;Biol Blood Marrow Transplant,2011

5. Decreased incidence of hepatic veno-occlusive disease and fewer hemostatic derangements associated with intravenous busulfan vs oral busulfan in adults conditioned with busulfan + cyclophosphamide for allogeneic bone marrow transplantation;Lee;Ann Hematol,2005

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Successful Treatment of Very Severe Sinusoidal Obstruction Syndrome After Gemtuzumab Ozogamicin With Transjugular Intrahepatic Portosystemic Shunt, Defibrotide, and High-Dose Corticosteroids: A Case Report;Cureus;2024-08-24

2. Prevention and management of acute toxicities from conditioning regimens during hematopoietic stem cell transplantation;Clinical Hematology International;2024-04-03

3. Immunotherapy for Acute Myeloid Leukemia: Current Trends, Challenges, and Strategies;Acta Haematologica;2023-09-06

4. New Therapeutic Strategies for Adult Acute Myeloid Leukemia;Cancers;2022-06-05

5. Two Different Transplant Preconditioning Regimens Combined with Irradiation and Chemotherapy in the Treatment of Childhood Leukemia: Systematic Review and Meta-Analysis;Journal of Healthcare Engineering;2022-03-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3